Emergent BioSolutions, Mount Sinai Health System Announce Initiation of Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin Product Candidate for Prophylaxis

Press/Media

Period31 Dec 2020

Media coverage

1

Media coverage

  • TitleEmergent BioSolutions, Mount Sinai Health System Announce Initiation of Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin Product Candidate for Prophylaxis
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date31/12/20
    PersonsJudith Aberg
View all 1
View less